Načítá se...

Angiopoietin-2 exacerbates cardiac hypoxia and inflammation after myocardial infarction

Emerging evidence indicates that angiopoietin-2 (Angpt2), a well-recognized vascular destabilizing factor, is a biomarker of poor outcome in ischemic heart disease. However, its precise role in postischemic cardiovascular remodeling is poorly understood. Here, we show that Angpt2 plays multifaceted...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Clin Invest
Hlavní autoři: Lee, Seung-Jun, Lee, Choong-kun, Kang, Seok, Park, Intae, Kim, Yoo Hyung, Kim, Seo Ki, Hong, Seon Pyo, Bae, Hosung, He, Yulong, Kubota, Yoshiaki, Koh, Gou Young
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Clinical Investigation 2018
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6205384/
https://ncbi.nlm.nih.gov/pubmed/30295643
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI99659
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!